t(14;22)(q32;q11) IGH/IGL

2008-06-01   Jan Delabie , Hege Vangstein Aamot 

1.Section for Cancer Cytogenetics, Department of Medical Genetics (HVA); Department of Pathology, Rikshospitalet University Hospital, Montebello, 0310 Oslo, Norway (JD)

Clinics and Pathology


Lymphoid malignancies


t(14;22)(q32;q11) analysed by G-banding has been reported in ALL, CLL/SLL, HCL, AML, NHL. Involvement of the genes IGH at 14q32 and IGL at 22q11 has been detected in one SLL and one DLBCL with t(14;22)(q32;q11).

Phenotype stem cell origin

  • Small lymphocytic lymphoma (SLL): CD20+, CD23+, CD5+, CD10-, cyclinD1-
  • Diffuse large B cell lymphoma (DLBCL): CD20+, BCL6+, CD10-, BCL2+
  • Clinics

  • SLL: Cervical lymphadenopathy
  • DLBCL: Generalized lymphadenopathy, night sweats, weight loss
  • Pathology

  • SLL: The lymph node showed diffuse infiltration with small lymphocytic cells with typical coarse clumped nuclear chromatin. Proliferation centers with paraimmunoblasts were present.
  • DLBCL: Diffuse proliferation of large atypical lymphoid cells
  • Cytogenetics

    Cytogenetics morphological

    The t(14;22)(q32;q11) was seen as the sole rearrangement in the SLL case. In the DLBCL case, there were several additional rearrangements. The complete karyotype of the latter was 52,XY,+Y,+der(3)t(3;9)(p11;p21),del(3)(q21),+7,+9,der(9)t(3;9)(q21;p21)x2,t(14;22)(q32;q11),der(15)t(1;15)(q21;p11),del(16)(p13),i(17)(q10),+18,+mar. The apparently identical translocation by G-banding has been seen in chronic myeloid leukaemia as well. However, this has been shown to be a three-way variant translocation of the classical t(9;22)(q34;q11) involving the genes ABL (9q34) and BCR (22q11).

    Cytogenetics molecular

    Fluorescence in situ hybridization (FISH) analysis with locus-specific probes covering parts of IGH (PAC 998D24) and IGL (PAC 1019H10) showed fusion signals between the two probes. In the DLBCL case (figure to the left), two fusion signals were seen, indicating a reciprocal translocation between the two genes. In the SLL case (figure to the right), however, only the IGL probe was split and moved close to the IGH probe. The IGH probe remained seemingly intact on the der(14). To pinpoint more exact the breakpoint in IGL, three segments of the IGL probe were made using Long Range PCR. These segments were used as probes in further FISH analyses. In the SLL case, a split signal in the first segment probe was seen, locating the breakpoint between 12600bp and 37000bp from the centromeric end of the IGL probe. In the DLBCL case, a split signal in all the three segments was seen. One explanation might be that the IGL was duplicated and that one copy was moved to der(14). Another explanation might be that there was more than one breakpoint within IGL.
    Atlas Image
    The left image shows FISH analysis on an interphase nuclei from the SLL case and the right image shows FISH analysis on a metaphase spread from the DLBCL case. The arrows point to the fusion signals of the IGH (PAC 988D24, 14q32) and IGL (PAC 1019H10, 22q11) probes. In the DLBCL case, a reciprocal translocation was seen where both IGH and IGL probes were split and juxtaposed. In the SLL case, however, only the IGL probe was split and moved to der(14).

    Genes Involved and Proteins

    Gene name
    IGH (Immunoglobulin Heavy)
    Dna rna description
    IGH is composed of variable (IGHV), diversity (IGHD), joining (IGHJ), and constant (IGHC) segments.
    Protein description
    IGH encodes the immunoglobulin heavy chains.
    Gene name
    IGL (Immunoglobulin Lambda)
    Dna rna description
    IGL is composed of variable (IGLV), joining (IGLV), and constant segments (IGLC).
    Protein description
    IGL encodes the immunoglobulin lambda chains.

    Result of the Chromosomal Anomaly


    Rearrangements of the three immunoglobulin genes IGK (2p12), IGH (14q32), and IGL (22q11) are often seen, especially in NHL, but it is uncommon that these genes are recombined with each other. None of these genes are known oncogenes, so how juxtaposition or fusion of the IGH and IGL in the t(14;22)(q32;q11) might act pathogenetically is completely unknown. In the SLL case, a gene dose effect of the IGL may be important if there really are two copies of the gene. However, how this may contribute to lymphoma development is not understood. In the DLBCL case, only the IGL probe was split and moved to der(14). There is a possibility that there is another, nearby gene that is involved and not the IGH. On the other hand, the breakpoint may be distal to our IGH probe and still be within the IGH gene.

    Highly cited references

    Pubmed IDYearTitleCitations
    195877642009Mechanisms promoting translocations in editing and switching peripheral B cells.70
    291003652017The value of detecting immunoglobulin gene rearrangements in the diagnosis of B-cell lymphoma.4
    319381302018A case study of t(14;22)(q32;q11) involving immunoglobulin heavy and light chain in follicular lymphoma.0


    Pubmed IDLast YearTitleAuthors
    161568542005t(14;22)(q32;q11) in non-Hodgkin lymphoma and myeloid leukaemia: molecular cytogenetic investigations.Aamot HV et al


    Fusion gene

    IGH/IGL IGH (14q32.33) IGL (22q11.22) M t(14;22)(q32;q11)
    Atlas Image
    t(14;22)(q32;q11) shown in ideograms and in G-banding. Both normal and rearranged chromosomes are shown. Arrows indicate the positions of the breakpoints - Courtesy Hege Vangstein Aamot, Jan Delabie; bottom row: Courtesy H. Norback, Eric B. Johnson, Sara Morrison-Delap UW Cytogenetic Services .


    Jan Delabie ; Hege Vangstein Aamot

    t(14;22)(q32;q11) IGH/IGL

    Atlas Genet Cytogenet Oncol Haematol. 2008-06-01

    Online version: http://atlasgeneticsoncology.org/haematological/1076/t(14;22)(q32;q11)